ERBB2 and neoplasm: A GC is Her2/neu positive, when ≥10% of the tumor cells show strong circumferential, lateral, or baso-lateral immunostaining, or when ≥10% of the tumor cells show weak to moderate circumferential, lateral, or baso-lateral immunostaining in combination with HER2/neu gene amplification.